Evidence map›Paper›PMID 39513084›Full record

ReviewJMA journal2024

Methods to Enhance Accessibility of Japanese Medical Literature in English Journals.

Kosuke Kojo, Bryan J Mathis, Takeshi Yamada, Hiroyuki Nishiyama, Takeshi Machino

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in JMA journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Kosuke KojoTsukuba Clinical Research & Development Organization, University of Tsukuba, Tsukuba, Japan.
Bryan J MathisClinical Trial Promotion Group, Institute of Medicine, University of Tsukuba, Tsukuba, Japan.
Takeshi YamadaTsukuba Clinical Research & Development Organization, University of Tsukuba, Tsukuba, Japan.
Hiroyuki NishiyamaTsukuba Clinical Research & Development Organization, University of Tsukuba, Tsukuba, Japan.
Takeshi MachinoTsukuba Clinical Research & Development Organization, University of Tsukuba, Tsukuba, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To address the challenges of accurately citing Japanese medical literature in English journals, the essential guidelines "Citing Medicine" by the National Library of Medicine were reviewed, focusing on practical adjustments to enhance accessibility. Key proposals include the use of persistent identifiers (Digital Object Identifier, PubMed Identifier, and International Standard Book Number), proper citation of online content, and the inclusion of romanized Japanese article titles. The selection of accessible journal titles and the importance of consistency were also discussed to avoid confusion. Given the significant volume of Japanese medical literature, cross-lingual citation is critical for preventing the isolation of scientific discoveries. These proposals highlight the need for improved citation practices to make Japanese research activities more accessible to the global research community.

Indexed as

AccessibilityAMA Manual of StyleBibliographic managementCitation guidelinesCross-lingual citationJapanese medical literatureRomanizationVancouver style

Identifiers

PMID39513084
PMCPMC11543340

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.